Concomitant Valve-sparing Aortic Root Replacement with Repair of Tetralogy of Fallot.

Concomitant Valve-sparing Aortic Root Replacement with Repair of Tetralogy of Fallot. Ann Thorac Surg. 2019 Feb 08;: Authors: Adachi O, Suzuki T, Yoshioka I, Takahashi G, Akiyama M, Kumagai K, Tatebe S, Saiki Y Abstract Valve-sparing aortic root replacement is one of the effective repairs for aortic regurgitation resulting from progressive dilatation of the aortic root late after surgical correction of conotruncal anomaly. However, feasibility and effectiveness of this procedure are unknown for unrepaired physiology. A 32 year-old man presented with unrepaired Tetralogy of Fallot (TOF) and moderate aortic regurgitation with severe left ventricular dysfunction. Valve-sparing aortic root replacement and TOF repair were simultaneously performed. Six months after the surgery, aortic regurgitation remained trivial. Concomitant valve-sparing aortic root replacement with TOF repair can be feasible and effective for unrepaired TOF with aortic regurgitation. PMID: 30742820 [PubMed - as supplied by publisher]
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Ann Thorac Surg Source Type: research

Related Links:

We present a rare case of severe aortic stenosis with a unicommissural unicuspid aortic valve diagnosed by preoperative transesophageal echocardiography in a 36-year-old man. After composite graft replacement of the aortic valve, aortic root, and ascending aorta, a permanent pacemaker was placed because of postoperative complete heart block. PMID: 31624715 [PubMed]
Source: Korean Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Tags: Korean J Thorac Cardiovasc Surg Source Type: research
To evaluate the outcomes of robotic mitral valve repair (MVr) by primary indication per American Heart Association guidelines for surgery: class I vs class IIa.
Source: Mayo Clinic Proceedings - Category: Internal Medicine Authors: Tags: Original article Source Type: research
We report a case of an 84-year-old Japanese female patient with transcatheter valve embolization treated with thoracic endovascular stenting. She was diagnosed with severe aortic stenosis and referred to our hospital. Transapical transcatheter aortic valve implantation (TA-TAVI) was selected because she had multiple comorbidities and peripheral vascular disease. During TA-TAVI, the transcatheter valve (TV) came loose and lodged in the distal aortic arch. The TV was floating and unstable, thereby affecting her hemodynamics. After a second TV was placed in the appropriate position with no trouble, we tried fixing the TV usin...
Source: General Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
The authors regret that there is a type error in the introduction section, the mid-nineteenth century needs to be, replaced with mid twentieth century.
Source: Heart, Lung and Circulation - Category: Cardiology Authors: Tags: Corrigendum Source Type: research
Last month, Medtronic announced receipt of U.S. Food and Drug Administration (FDA) approval for and launch of the Evolut Pro+ TAVR (Transcatheter Aortic Valve Replacement) System to treat patients with symptomatic severe aortic stenosis. Aortic steno...
Source: Medgadget - Category: Medical Devices Authors: Tags: Cardiac Surgery Cardiology Exclusive Source Type: blogs
Change is in the air for Admedus. The Brisbane, Australia-based company is selling off its CardioCel and VascuCel businesses to LeMaitre Vascular. The deal would give Admedus the space to focus on its transcatheter aortic valve replacement products. Under the agreement terms, Admedus receives $A22.8 million upfront followed by deferred payments of $A1 million each at 12 months and at 36 months. Additionally, the company could receive up to $A11.4 million in earn-out payments. Admedus said it retains manufacturing rights for up to three years and will continue manufacturing CardioCel and VascuCel at its Malaga facility in W...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Cardiovascular Source Type: news
ConclusionOur patients in this cohort demonstrated the well ‐established benefits of robotic sternal‐sparing cardiac surgery, including excellent intra and postoperative outcomes and accelerated recovery.
Source: Journal of Cardiac Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: ORIGINAL ARTICLE Source Type: research
ConclusionsToday, BAV repair leads to excellent stability if an anatomy-oriented concept is used. Further improvements of cinical results and reproducibility can be anticipated.
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
Publication date: Available online 10 October 2019Source: The Annals of Thoracic SurgeryAuthor(s): Pouya Youssefi, Carlotta Brega, Nathanael Shraer, Pavel Zacek, Mathieu Debauchez, Emmanuel Lansac
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
In this study, the hemodynamics of the right ventricle (RV) after (i) clover edge-to-edge tricuspid repair and (ii) double orifice tricuspid repair was evaluated in three right heart models using an ex vivo pulsatile platform emulating severe FTR with the aid of stereoscopic particle image velocimetry. Although all repairs substantially reduced tricuspid regurgitant area, they resulted in more than 50% reduction in diastolic tricuspid valve (TV) opening area. Splitting the TV orifice into multiple smaller orifices by both repairs eliminated the ring-shaped vortical structure inside the RV observed in FTR cases. Post-repair...
Source: American Journal of Physiology. Heart and Circulatory Physiology - Category: Physiology Authors: Tags: Am J Physiol Heart Circ Physiol Source Type: research
More News: Cardiovascular & Thoracic Surgery | Gastroschisis Repair | Heart Valve Surgery | Physiology | Science